Locations
Los Angeles, CA, USA · Culver City, CA, USA
industry
Biotechnology · DeepTech · Health
Stage
Series B
founded in
2018
TORL Bio Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of antibody-based therapies aimed at improving and extending the lives of cancer patients globally. The company is developing a robust pipeline of monoclonal antibodies and antibody-drug conjugates targeting novel cancer indications identified through a strategic partnership with the Slamon Research Lab at UCLA. With a highly experienced executive team and collaborations with global clinical research networks, TORL is positioned to address significant unmet medical needs in oncology through its innovative therapies.
Something looks off?